This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Asia
October 20-22, 2025
Westin MiyakoKyoto, Japan

Takashi Kaminagayoshi
Head of Biotherapeutics Process Development - Japan at Takeda Pharmaceutical Company Limited, Japan
Speaker

Profile

With two decades of expertise in device development—including bioreactors—process engineering, and project management at Hitachi, I have led numerous pharmaceutical facility projects worldwide for high-potency drug substances and biologics. Since joining Takeda in 2010, I have spearheaded Japan’s first GMP manufacturing of therapeutic antibodies at production scale, helping establish foundational capabilities in biologics. Focused on advancing biologics process development through cutting-edge technologies such as automation and continuous processing, I hold a Ph.D. in Life Science and an MBA (MOT) from Yamaguchi University, along with a JDLA Deep Learning for GENERAL Certificate. I also serve as Biopharmaceutical COP Leader of the ISPE Japan Affiliate and as a representative on the Biopharmaceutical Committee of the JPMA.

Agenda Sessions

  • Chairperson’s Remarks: Achievements in Intensified, Continuous, and Sustainable Bioprocessing

    13:55